Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715)

Sun Pharmaceutical Industries Ltd. (Sun) is a specialty pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations as branded generics, as well as generics, in the United States, India and other markets. It operates through four segments: US Generics, Indian Branded Generics, International Branded Generics (rest of the world, except the United States) and Active Pharmaceutical Ingredients (API). Sun manufactures specialty APIs, including peptides, steroids, hormones and anticancers. The Company’s API products include Acamprosate Calcium, Alendronate Sodium, Bortezomib, Cisplatin, Choline Fenofibrate and Carvedilol. It offers products across five continents in over 150 nations with a presence in the United States, India, Asia, Europe, South Africa, Commonwealth of Independent States and Russia, and Latin America. It also offers specialty and generic products across a range of chronic and acute prescription drugs.

Official website: www.sunpharma.com